To examine the association of components of the metabolic syndrome with lower urinary tract symptoms (LUTS), which often result from prostate enlargement and heightened tone of prostate and bladder smooth muscle. DESIGN: Third National Health and Examination Survey (NHANES III), from which LUTS cases and controls were selected. SUBJECTS: A total of 2372 men aged 60 þ y who participated in NHANES III. LUTS cases were men with at least three of these four symptoms: nocturia, incomplete bladder emptying, weak stream, and hesitancy, and who never had noncancer prostate surgery. Controls were men without any of the symptoms and who never had noncancer prostate surgery. MEASUREMENTS: As part of NHANES III, an oral glucose tolerance test was carried out, glycosylated hemoglobin, HDL and LDL cholesterol, and triglycerides were measured, and history of diabetes mellitus and hypertension were assessed. Logistic regression was used to calculate odds ratios (ORs) after applying sampling weights. RESULTS: History of diabetes (OR 1.67; 95% confidence interval (CI) 0.72-3.86) and hypertension (OR 1.76; 95% CI 1.20-2.59) appeared to be positively associated with LUTS. The odds of LUTS increased with increasing glycosylated hemoglobin (Ptrend ¼ 0.005). No statistically significant associations between fasting or 2-h glucose or fasting insulin and LUTS were observed. However, men classified as having three or more components of the metabolic syndrome had an increased odds of LUTS (OR ¼ 1.80; 95% CI 1.11-2.94). CONCLUSION: These findings support the role for metabolic perturbations in the etiology of LUTS.
Introduction
Men of older age often experience lower urinary tract symptoms (LUTS) that frequently are due to benign prostatic hyperplasia (BPH). Besides the observation that the prevalence of LUTS increases with age, not much is known about the risk factors for this bothersome condition. Based on the observation in a clinic-based study of 158 patients that an enlarged prostate is more often diagnosed in men who have components of the metabolic syndrome, such as noninsulindependent diabetes mellitus, hypertension requiring treatment, low HDL-cholesterol levels, higher fasting insulin levels, and obesity, Hammarsten et al 1 suggested that the development of an enlarged prostate might be the result of perturbations in insulin control and other aspects of the metabolic syndrome. Recently, in a population-based sample of African-American men aged 40-79 y, Joseph et al 2 reported
that men with a diagnosis of diabetes mellitus or hypertension had a higher odds of having moderate to severe LUTS. We used data from the Third National Health and Nutrition Examination Survey (NHANES III), a cross-sectional study representative of the US population conducted between 1988 and 1994, to examine whether medical or biochemical indicators of the metabolic syndrome are associated with LUTS.
Subjects and methods

Study population
Between 1988 and 1994, the National Center for Health Statistics conducted NHANES III. This cross-sectional study consisted of a multistage stratified, clustered probability sample of the U.S. civilian, noninstitutionalized population at least 2 months of age. Mexican Americans, non-Hispanic blacks, and the elderly were oversampled to ensure minimum sample sizes of these population groups. Included in the present analysis were NHANES III participants, aged 60 y and older, who participated in an interview conducted at home and who had an extensive physical examination. Of 3117 eligible men, we excluded men who had a mobility impairment (n ¼ 103), were not the sample person (n ¼ 133), who were previously diagnosed with prostate cancer (n ¼ 84), or who did not participate in the physical examination at the Mobile Examination Center (n ¼ 425), leaving 2372 men.
Outcome assessment
We used the following four questions to characterize LUTS: (a) how many times per night do you usually get up to urinate (pass water)? ('nocturia'), (b) when you urinate (pass water), do you usually feel like you have not completely emptied your bladder? ('incomplete emptying'), (c) do you usually have trouble starting to urinate (pass water)? ('hesitancy'), and (d) has the force of your urinary stream of water decreased over the years? ('weak stream'). These are four of the seven symptoms of the American Urological Association symptom index which additionally includes frequency, intermittence, and urgency. 3 The men also were asked if they ever had surgery for their prostate not related to cancer ('noncancer prostate surgery'). In the present analysis, we considered men as having LUTS if they reported three or four of the symptoms (excluding those men who reported noncancer prostate surgery). Nocturia was included as a symptom when men had to get up at least twice per night. The comparison group consisted of men who did not report any of the four symptoms and never had noncancer prostate surgery. Men with only one or two symptoms were not considered to be cases nor were they included in the comparison group. Noncancer prostate surgery was not considered in this analysis because the date of surgery may have preceded date of examination by several years, making temporal influences unclear.
Exposure assessment
Blood was drawn during an examination session at the Mobile Examination Center 4 and an oral glucose tolerance testing (OGTT) was conducted on examinees aged 40-74 y and who currently did not use insulin therapy. 4 Approximately half of the men who underwent OGTT did so after an overnight fast of at least 9 h. As part of NHANES III, plasma glucose was measured using a hexokinase enzymatic method. Glycosylated hemoglobin (Hb A1c ) was measured using an ion-exchange high-performance liquid chromatography method using the Diamat Analyzer System. Insulin was measured by a radioimmunoassay. Two-hour insulin was measured only in sample persons recruited between 1991 and 1994 and was not considered in our analysis because of small sample size. The homeostasis model assessment (HOMA) was used to describe insulin resistance using the following formula: HO-MA ¼ (fasting insulin (pmol/l) * 0.167) * fasting glucose (mmol/l)/22.5. 5 Total cholesterol and triglycerides were measured enzymatically. HDL-cholesterol was assessed following the precipitation of the other lipoproteins with a polyanion/divalent cation mixture. The value for LDLcholesterol was calculated for men who fasted overnight for at least 9 h by the Friedewald equation as follows: LDLcholesterol ¼ total cholesterolÀHDL-cholesterolÀtriglycer-riglyceride/5. We calculated the total cholesterol:HDL-ratio as a measure of dyslipidemia by dividing a man's total cholesterol concentration by his HDL-cholesterol concentration. 6 Analytical methods and quality control protocols have been described in detail elsewhere. 4, 7 Waist circumference and blood pressure were measured during the physical examination. The consumption of alcoholic beverages (beer, wine, liquor) was assessed using a food frequency questionnaire and we grouped men whether they did not drink alcohol, whether they had up to one alcoholic beverage per week, more than one drink per week but less than one drink per day, or whether they had one drink per day or more. The consumption of caffeinated beverages was also assessed in the food frequency questionnaire and we grouped men whether they did not drink caffeinated beverages, whether they had less than one caffeinated beverage per day, one or two per day, or more than two caffeinated beverages per day. Men were classified according to their current smoking habit into current (1-34 or Z35 cigarettes per day), former, or never smokers. Frequency of physical activity was obtained during the interview and men were grouped by their weekly frequency of moderate and vigorous activity. Men were categorized as having a history of diabetes if they currently used insulin or oral diabetes medication or if their doctor had told them that they had diabetes. Men were considered to have a history of hypertension if they currently used hypertension medication or if they were told by their doctor on two occasions that they had hypertension/high blood pressure.
We defined the metabolic syndrome as having at least three of the following five components: (a) waist circumference 4102 cm, (b) triglycerides concentration Z1.69 mmol/ l, (c) HDL-cholesterol level o1.03 mmol/l, (d) systolic blood pressure Z130 mmHg, or diastolic blood pressure software were used for the statistical analysis. We used sample weights that took into account the specific probabilities of selection for the individual domains that were oversampled in NHANES III, nonresponse, and differences between demographic characteristics of the sample and the total U.S. population. 4 The analysis of the biochemical markers was restricted to the subset of men who had fasted overnight for at least 9 h (n ¼ 1075) except for glycosylated hemoglobin, which is not affected by fasting status. Although serum HDL concentration is not affected by fasting status, we showed the results for men with an overnight fast to make the results comparable among the fat metabolism markers. Testing for differences between men with and without LUTS was carried out using the t-test for continuous and the w 2 test for categorical variables. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence interval (CI) of having LUTS for the medical or biochemical measures adjusting for age (in 5-y categories) and race (nonHispanic black, non-Hispanic white, Mexican-American, other). We evaluated whether possible risk factors for LUTS were confounders of the associations of the medical and biochemical indicators of insulin, glucose, and fat metabolism with LUTS by including waist circumference (or body mass index), alcohol intake, consumption of caffeinated beverages, cigarette smoking, and physical activity in the models. Since the results were not appreciably changed after multivariate adjustment, we only show the results adjusted for age and race. Trend tests were performed by assigning to each subject the median value for the category of the risk factor into which the subject fell and modeling this term as a continuous variable, the coefficient for which was evaluated by the Wald test.
Results
Of all men who participated in the medical examination, 10.7% had three or four symptoms (but no surgery) and 27.6% reported neither LUTS nor noncancer prostate surgery. This distribution was similar in the subsample of men with an overnight fast of at least 9 h (9.1 and 31.4%, respectively). Men with LUTS were statistically significantly older than men without LUTS and had fewer years of education (Table 1) . Men with LUTS were also more likely to use diuretics than men without LUTS and less likely to consume alcohol, although these differences were not statistically significant. Among the men who participated in the physical examination, the prevalence of a history of diabetes was 15.2 and 10.9% (P ¼ 0.31) among men with and without LUTS (Table 2) , respectively, and a history of diabetes was associated with a slightly, but not statistically significant, higher odds of LUTS (OR 1.67; 95% CI 0.72-3.86). A history of hypertension was more common in men with LUTS (40.9%) compared with men without symptoms (28.3%) (P ¼ 0.008); men with a history of hypertension had a significantly higher odds of LUTS than men who did not (OR 1.76; 95% CI 1.20-2.59). Consumption of both alcoholic and caffeinated beverages might confound the association of hypertension with LUTS. However, adjusting for the consumption of these two types of beverages did not alter the association (OR ¼ 1.76; 95% CI 1.14-2.71). Excluding men who used diuretics only slightly attenuated the association of hypertension with LUTS (OR ¼ 1.65; 95% CI ¼ 1.02-2.66). Almost two-thirds of all men had a blood pressure measure that was considered to be high (systolic blood pressure Metabolic syndrome and lower urinary tract symptoms S Rohrmann et al Z130 mmHg or diastolic blood pressure Z85 mmHg) during the physical examination (Table 2 ) and these men had a nonstatistically significantly elevated odds of LUTS (OR 1.28; 95% CI 0.94-1.76). LUTS cases had statistically significant higher glycosylated hemoglobin than men without symptoms (Table 2) . Increasing level of glycosylated hemoglobin was associated with a higher odds of LUTS (P-trend ¼ 0.004) ( Table 3 ). This trend was still significant after excluding men with a history of diabetes mellitus (P-trend ¼ 0.008). Additionally, excluding men with an impaired fasting glycemia (fasting glucose concentration Z6.1 mmol/l) led to an attenuation of the association, with a trend of borderline significance (Ptrend ¼ 0.06). Among men with an overnight fast of at least 9 h, mean fasting and 2-h glucose (the latter only in men 60-74 y of age), fasting insulin, and HOMA were not statistically significantly higher in LUTS cases than in controls ( Table 2) . We observed a higher odds of LUTS in men with an increased 2-h postload glucose concentration (Table 3 ), but the ORs were not monotonically increasing. The ORs in the second, third, and fourth quartiles of fasting glucose and insulin were all above 1. However, these associations were not all statistically significant.
We observed a lower mean serum HDL-cholesterol concentration in men with LUTS compared with men without ( Table 2 ). The mean total cholesterol, LDL-cholesterol, total cholesterol: HDL ratio, and triglycerides were not statistically significantly different between cases and controls. A higher HDL-cholesterol concentration was associated with a nonstatistically significant lower odds of LUTS (Table 4 ). Higher levels of LDL-cholesterol, total cholesterol:HDL ratio and triglycerides were each associated with an elevated odds of LUTS, although the trends were not statistically significant.
The presence of the metabolic syndrome was not statistically significantly associated with LUTS (OR ¼ 1.17; 95% CI 0.83-1.65). However, the OR was elevated in men with at least four components of the metabolic syndrome (OR ¼ 1.61; 95% CI 1.01-2.56) compared with men with fewer components. When we used the second, more specific definition of metabolic syndrome, we observed an even stronger association (OR ¼ 1.80; 95% CI 1.11-2.94). These Metabolic syndrome and lower urinary tract symptoms S Rohrmann et al associations remained after adjusting for body mass index and after excluding men who used diuretics. Excluding men with a history of diabetes from the analysis slightly attenuated the associations (having four or more components of the metabolic syndrome: OR ¼ 1.61, 95% CI 0.99-2.62; using the more specific metabolic syndrome definition: OR ¼ 1.55; 95% CI 0.83-2.88). To determine whether waist circumference or the other components of the metabolic syndrome was the greater contributor to the association with LUTS, we adjusted for waist circumference. Doing so did not appreciably attenuate the association between the presence of the metabolic syndrome, independent of its definition, and LUTS.
Discussion
In this sample of older US men, we examined the crosssectional association of medical and biochemical markers of the metabolic syndrome with LUTS. We observed a strong positive association between glycosylated hemoglobin, a time-integrated marker of average glycemia over the past 3 months, and LUTS and suggestions of associations for history of diabetes and other biochemical markers of insulin and glucose control. We also noted a positive association for history of hypertension and suggestions of an inverse association for HDL-cholesterol and positive associations for other biochemical markers of fat metabolism. Combining all markers of the metabolic syndrome, we did not observe a statistically significantly elevated odds of LUTS in men with at least three components of the metabolic syndrome. However, the association with LUTS was stronger and statistically significant when we used two more specific definitions of the metabolic syndrome. We previously found that waist circumference was positively associated with LUTS in NHANES III. 10 The associations for the more specific definitions of the metabolic syndrome persisted after adjustment for waist circumference, suggesting that waist circumference is not a more important contributor to the association of the metabolic syndrome with LUTS than other components of the metabolic syndrome. Dahle et al 11 observed an almost 2.5-fold increased odds of BPH in Chinese men in the highest quartile of serum insulin compared with men in the lowest quartile. Hammarsten et al 1 reported a highly significant correlation between prostate size and fasting insulin levels. In our study, we did not observe a statistically significant positive association of LUTS with higher levels of fasting insulin. Owing to the large intraindividual variation, a one-time measurement of glucose, insulin, or HOMA has only a low ability to characterize a person's glycemic level. 12 In contrast, glycosylated hemoglobin is an indicator of average glycemia for the previous 3 months 13 and, therefore, a better marker of long-term glucose metabolism, and likely insulinemia, than a single glucose or insulin measurement. We also observed a moderately elevated, not statistically significant, odds of LUTS in men with a history of diabetes, which was consistent with previous studies. 1,2 Our findings for the biochemical markers of fat metabolism and hypertension also support the observations by Hammarsten et al for prostate size and prostate growth.
1,14
Hammarsten and Högstedt 14 suggested that BPH might be an insulin-resistance condition with secondary hyperinsulinemia as a possible etiological factor for prostate enlargement. Insulin might influence two pathologies that lead to LUTSFprostate growth and increased tone of prostate smooth muscle as well as of bladder smooth muscle. Firstly, because of its structural similarity to insulin-like growth factor (IGF), insulin can bind to the IGF receptor, activate it, and possibly induce prostate growth. 11 Also, as insulin increases IGF-binding protein (IGFBP)-1 declines, thus, possibly increasing the bioavailability of IGF. Components of the IGF axis have been found to be associated with the risk of BPH and LUTS in previous studies. [15] [16] [17] Secondly, BPH patients with hyperinsulinemia might have increased sympathetic nervous system activity 1 because insulin resistance is associated with sympathetic activation 18 and higher systemic sympathetic nervous activity would likely contribute to an increase of prostate smooth muscle tone. Additionally, heightened sympathetic nervous system activity might affect the tonus of the bladder muscles. 19 Alternatively, hyperglycemia itself might play a role by increasing cystolic-free calcium in smooth muscle cells as well as in neural tissue, thus, leading to sympathetic nervous system activation. 20 This would coincide with our observation of a higher odds of LUTS in men with elevated postload glucose concentration as well as with a higher percentage of glycosylated hemoglobin compared with men with lower Metabolic syndrome and lower urinary tract symptoms S Rohrmann et al levels. Changes in insulin and glucose metabolism have also been found to be associated with hypertensionFvia stimulation of the sympathetic nervous system activity 21 Fand dyslipidemia, which have been observed to be associated with prostate size and LUTS by others. 1, 2 Third, fasting insulin levels are thought to be inversely associated with serum concentrations of testosterone and SHBG. 22 Low levels of testosterone might play a role in the pathogenesis of insulin resistance, the development of the metabolic syndrome, and diabetes through effects on body composition and fat distribution. 23 However, serum testosterone concentration has not been consistently associated with the risk of BPH and LUTS. 24, 25 Alternatively, a lower level of SHBG might cause higher levels of free estrogen, 26 which have been found to be associated with a higher risk of BPH in some, 24, 25 but not all studies. 27 Several aspects of our analysis merit further discussion. First, in the analysis of biochemical markers (except glycosylated hemoglobin), we included only men who fasted overnight for at least 9 h before the blood was drawn. This subsample closely conforms to the 1995 World Health Organization criteria for OGTT testing to identify diabetes. 28 By excluding men who did not fast for at least 9 h, we limited the extent of measurement error and underestimation of the associations. Second, 2-h glucose measurements were available only for men who were younger than 75 y of age. When we restricted the analysis for fasting glucose to men who were younger than 75 y of age, the result was similar to that for all men. Since glucose tolerance declines with age, we speculate that we might have observed an even stronger result in older men.
Third, we used two different definitions for the metabolic syndrome, one that was likely more sensitive and the other that was likely more specific. The more sensitive definition likely also captures men with undiagnosed diabetes based on their fasting glucose level, which we did not include as a separate analysis. Owing to the intraindividual variation in both fasting glucose levels and blood pressure, a one-time measurement may not be adequately specific such that some persons without diabetes or hypertension may be misclassified. Therefore, we defined a second, more specific score, which yielded a higher OR.
Fourth, diabetes causes glycosuria, which then induces polyuria, nocturia, and bladder emptying. Additionally, diabetic autonomic neuropathy can cause LUTS such as incomplete emptying, weak stream, or frequency. 29 We cannot rule out that a portion of the symptoms was caused by diabetic bladder dysfunction; however, we believe that this is not the explanation for our observation, especially because we did not observe strong attenuations of the association of glycosylated hemoglobin or the metabolic syndrome after we excluded men with a history of diabetes or users of diuretics from the analysis. Further supporting our results is that a higher prevalence of fast-growing prostate size was associated with several symptoms of the metabolic syndrome in a small sample of men followed prospectively.
14 Fifth, we considered men to be LUTS cases if they reported at least three of the four AUA symptoms that were asked during the interview and did not consider men who reported only one or two symptoms to rule out a high false-positive rate. Sixth, we cannot completely rule out that some men in the control group did not report LUTS due to use of medications. However, this is unlikely because NHANES III was conducted between 1988 and 1994 and medications for the treatment of BPH was approved in the early 1990s (Finasteride in June 1992 30, 31 and terazosin in November 1993 32 ). Seventh, we did not rely on a physician's diagnosis of symptomatic enlarged prostate, which could possibly have resulted in detection bias, but on urinary symptoms that were assessed during a representative survey. Men with metabolic syndrome may be more likely to visit their physician more often than men without metabolic syndrome and, thus, have a greater opportunity to be diagnosed with symptomatic enlarged prostate. In addition, LUTS is not specific to BPH; some men may have urinary symptoms because of bladder outlet dysfunction. 33 Finally, the prevalence of LUTS and the medical and biochemical markers of the metabolic syndrome were assessed concurrently. Therefore, our results reflect associations and do not prove any causal effect.
In conclusion, our findings suggest that components of the metabolic syndrome are associated with LUTS in older men. Further research is desirable to explore whether perturbations of glucose/insulin and fat metabolism and the development of the metabolic syndrome influence prostate growth and the smooth muscle tone of prostate and bladder and, thus, the development of LUTS and BPH additionally in younger and middle-aged men. Further work is needed to determine if improved control of glucose, insulin, cholesterol, and blood pressure would reduce the extent of LUTS in aging men. Most of these factors can, at least in part and beyond any other medication, be positively influenced by more physical activity, lower energy intake, and thus, lower body weight.
